These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20598408)

  • 1. Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.
    Kraigher A; Ucakar V
    Vaccine; 2010 Jul; 28(33):5467-72. PubMed ID: 20598408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing].
    Miao L; Lu L; Wu J; Suo LD; Liu DL; Sun MP; Pang XH; Deng Y; Wang XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct; 44(10):884-7. PubMed ID: 21176517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine safety.
    Labadie J
    Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.
    Choe YJ; Cho H; Kim SN; Bae GR; Lee JK
    Vaccine; 2011 Oct; 29(44):7727-32. PubMed ID: 21827815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
    Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
    Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(3):74-7. PubMed ID: 20110935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
    Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
    Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
    Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
    Schumacher Z; Bourquin C; Heininger U
    Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
    Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
    Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers.
    Lapphra K; Dobson S; Bettinger JA
    Vaccine; 2010 Aug; 28(38):6199-202. PubMed ID: 20654668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.